Annual ROE
-53.22%
+3.88%+6.80%
November 30, 2024
Summary
- As of February 7, 2025, NRIX annual return on equity is -53.22%, with the most recent change of +3.88% (+6.80%) on November 30, 2024.
- During the last 3 years, NRIX annual ROE has fallen by -16.17% (-43.64%).
- NRIX annual ROE is now -241.54% below its all-time high of 37.60%, reached on November 30, 2019.
Performance
NRIX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-58.88%
+6.64%+10.13%
November 30, 2024
Summary
- As of February 7, 2025, NRIX quarterly return on equity is -58.88%, with the most recent change of +6.64% (+10.13%) on November 30, 2024.
- Over the past year, NRIX quarterly ROE has increased by +4.77% (+7.49%).
- NRIX quarterly ROE is now -219.92% below its all-time high of 49.10%, reached on February 29, 2020.
Performance
NRIX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NRIX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.8% | +7.5% |
| 3 y3 years | -43.6% | +1.5% |
| 5 y5 years | -241.5% | +1.5% |
NRIX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.6% | +6.8% | -68.4% | +11.9% |
| 5 y | 5-year | -241.5% | +6.8% | -219.9% | +30.7% |
| alltime | all time | -241.5% | +6.8% | -219.9% | +30.7% |
Nurix Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2024 | -53.22%(-6.8%) | -58.88%(-10.1%) |
| Aug 2024 | - | -65.52%(-2.0%) |
| May 2024 | - | -66.87%(+5.1%) |
| Feb 2024 | - | -63.65%(+12.5%) |
| Nov 2023 | -57.10%(+2.3%) | -56.58%(+7.6%) |
| Aug 2023 | - | -52.58%(-3.3%) |
| May 2023 | - | -54.40%(-9.0%) |
| Feb 2023 | - | -59.80%(+3.5%) |
| Nov 2022 | -55.84% | -57.76%(+10.1%) |
| Aug 2022 | - | -52.47%(+14.7%) |
| May 2022 | - | -45.75%(+14.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2022 | - | -40.03%(+14.5%) |
| Nov 2021 | -37.05%(-0.4%) | -34.96%(+15.5%) |
| Aug 2021 | - | -30.28%(-6.7%) |
| May 2021 | - | -32.45%(+8.0%) |
| Feb 2021 | - | -30.06%(+12.4%) |
| Nov 2020 | -37.19%(-198.9%) | -26.74%(-13.8%) |
| Aug 2020 | - | -31.01%(-63.5%) |
| May 2020 | - | -84.95%(-273.0%) |
| Feb 2020 | - | 49.10%(+77.7%) |
| Nov 2019 | 37.60%(+46.9%) | 27.63% |
| Nov 2018 | 25.59% | - |
FAQ
- What is Nurix Therapeutics annual return on equity?
- What is the all time high annual ROE for Nurix Therapeutics?
- What is Nurix Therapeutics annual ROE year-on-year change?
- What is Nurix Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Nurix Therapeutics?
- What is Nurix Therapeutics quarterly ROE year-on-year change?
What is Nurix Therapeutics annual return on equity?
The current annual ROE of NRIX is -53.22%
What is the all time high annual ROE for Nurix Therapeutics?
Nurix Therapeutics all-time high annual return on equity is 37.60%
What is Nurix Therapeutics annual ROE year-on-year change?
Over the past year, NRIX annual return on equity has changed by +3.88% (+6.80%)
What is Nurix Therapeutics quarterly return on equity?
The current quarterly ROE of NRIX is -58.88%
What is the all time high quarterly ROE for Nurix Therapeutics?
Nurix Therapeutics all-time high quarterly return on equity is 49.10%
What is Nurix Therapeutics quarterly ROE year-on-year change?
Over the past year, NRIX quarterly return on equity has changed by +4.77% (+7.49%)